481
Views
52
CrossRef citations to date
0
Altmetric
Review

Guidelines for aerosol devices in infants, children and adults: which to choose, why and how to achieve effective aerosol therapy

&
Pages 561-572 | Published online: 09 Jan 2014

References

  • Dolovich MB, Ahrens RC, Hess DR et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest127, 335–371 (2005).
  • Molimard M, Rahersion C, Lignot S. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J. Aerosol Med.16, 249–254 (2003).
  • Watts AB, McConville JT, Williams RO 3rd. Current therapies and technological advances in aqueous aerosol drug delivery. Drug Dev. Ind. Pharm.34, 913–922 (2008).
  • Dalby R, Spallek M, Voshaar T. A review of the development of Respimat soft mist inhaler. Int. J. Pharm.283, 1–9 (2004).
  • Fink J, Hodder R. Adherence and inhaler devices in COPD. Respir. Ther.6, 28–33 (2011).
  • Fink JB. Aerosol drug therapy. In: Egan’s Fundamentals of Respiratory Care. Mosby Elsevier, MO, USA, 801–842 (2009).
  • Hess DR. Aerosol delivery devices in the treatment of asthma. Respir. Care53, 699–723 (2008).
  • Fink JB, Rubin BK. Aerosol and medication administration. In : Perinatal and Pediatric Respiratory Care. Czerviske MP, Barnhart SL (Eds). Elsevier Science MO, USA (2003).
  • Rau JL. Practical problems with aerosol therapy in COPD. Respir. Care51(2), 158–172 (2006).
  • Rubin BK. Nebulizer therapy for children: the device-patient interface. Respir. Care47(11), 1314–1319 (2002).
  • Boe J, Dennis JH, O’Driscoll BR et al. European respiratory society guidelines on the use of nebulizers. Eur. Respir. J.18(1), 228–242 (2001).
  • Everard ML. Aerosol delivery to children. Pediatr. Ann.35(9), 630–636 (2006).
  • Everard ML. Inhalation therapy for infants. Adv. Drug Deliv. Rev.55(7), 869–878 (2003).
  • Ahrens RC. The role of the MDI and DPI in pediatric patients: ‘children are not just miniature adults’. Respir. Care50(10), 1323–1328 (2005).
  • Pongracic JA. Asthma delivery devices: age-appropriate use. Pediatr. Ann.32(1), 50–54 (2003).
  • Rubin BK, Fink JB. Optimizing aerosol delivery by pressurized metered-dose inhalers. Respir. Care50(9), 1191–1200 (2005).
  • Rubin B, Fink J. The delivery of inhaled medication to the young children. Pediatr. Clin. North Am.50(3), 717–731 (2003).
  • Everard ML. Inhaler devices in infants and children: challenges and solutions. J. Aerosol Med.17, 186–195 (2004).
  • Everard ML. Guidelines for devices and choices. J. Aerosol Med.14(Suppl. 1), S59–S64 (2001).
  • Ritson SD, Everard ML. Aerosol delivery systems acceptable to young children improve drug delivery. Thorax53(Suppl. 4), A55 (1998).
  • Fink J. Aerosol delivery to ventilated infants and pediatric patients. Respir. Care49(6), 653–665 (2004).
  • Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir. Care50(10), 1360–1374 (2005).
  • Lewis RM, Fink JB. Promoting adherence to inhaled therapy: building partnerships through patient education. Respir. Care Clin. N. Am.7(2), 277–301 (2001).
  • Fink JB. Inhalers in asthma management: is demonstration the key to compliance? Respir. Care50(5), 598–600 (2005).
  • Cipolla D, Chan H, Schuster J, Farina D. Personalizing aerosol medicine: development of delivery systems tailored to the individual. Therapeutic Delivery1, 667–682 (2010).
  • Geller DE. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler. Respir. Care50(10), 1313–1321 (2005).
  • Rau JL. The inhalation of drugs: advantages and problems. Respir. Care50(3), 367–382 (2005).
  • Castro-Rodriguez JA, Rodrigo GJ. β-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis. J. Pediatr.145(2), 172–177 (2004).
  • Meadows-Oliver M, Banasiak NC. Asthma medication delivery devices. J. Pediatr. Health Care19(2), 121–123 (2005).
  • Nikander K, Agertoft L, Pedersen S. Breath-synchronized nebulization diminishes the impact of patient-device interfaces (face mask or mouthpiece) on the inhaled mass of nebulized budesonide. J. Asthma37(5), 451–459 (2000).
  • Rau JL, Ari A, Restrepo RD. Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric. Respiratory Care49(2), 174–179 (2004).
  • Silver W, Cohen R, D’Alonzo G et al. Comparative taste evaluation of aerosolized formulations of triamcinolone acetonide flunisolide and flunisolide with menthol. Clin. Ther.15(8), 988–993 (1993).
  • Osman L, Hyland M. Patient needs and medication styles in COPD. Eur. Respir. Rev.14(96), 89–92 (2005).
  • Crompton G. The adult patient’s difficulties with inhalers. Lung168, S658–S662 (1990).
  • Nikander K. Adaptive aerosol delivery: the principles. Eur. Respir. Rev.7, 385–387 (1997).
  • Denyer J. Adaptive aerosol delivery in practise. Eur. Respir. Rev.7, 388–389 (1997).
  • Nikander K, Arheden L, Denyer J, Cobos N. Parents’ adherence with nebulizer treatment of their children when using an adaptive aerosol delivery (AAD) system. J. Aerosol Med.16(3), 273–281 (2003).
  • Hussain-Rizvi A, Kunkov S, Crain EF. Does parental involvement in pediatric emergency department asthma treatment affect home management? J. Asthma46(8), 792–795 (2009).
  • Everard ML. Aerosol therapy: regimen and device compliance in daily practice. Paediatr. Respir. Rev.7(Suppl. 1), S80–S82 (2006).
  • Everard ML. Regimen and device compliance: key factors in determining therapeutic outcomes. J. Aerosol Med.19(1), 67–73 (2006).
  • van Essen Zandvliet E, Hughes M, Waalkens H, Duiverman E, Pocock S, Kerrebijn K. Effects of 22 months of treatment with inhaled corticosteroids and/or β-2 agonists on lung function, airway responsiveness and symptoms in children with asthma. Am. Rev. Resp. Dis.146, 547–554 (1992).
  • Haahtela T, Jarvinen M, Kava T et al. Comparison of a β-2 agonist, terbutaline with an inhaled corticosteroid, budesonide, in newly detected asthma. N. Engl. J. Med.325, 388–392 (1991).
  • van Der Palen J, Klein KC, van Herwaarden CL, Zielhuis G, Seydel E. Multiple inhalers confuse asthma patients. Eur. Respir. J.14(5), 1034–1037 (1999).
  • Pedersen S. Inhalers and nebulizers: which to choose and why? Eur. Respir. J.12, 1340–1345 (1996).
  • Geller DE. Clinical side effects during aerosol therapy: cutaneous and ocular effects. J. Aerosol Med.20(Suppl. 1), S100–S108 (2007).
  • Gulliver T, Morton R, Eid N. Inhaled corticosteroids in children with asthma: pharmacologic determinants of safety and efficacy and other clinical considerations. Paediatr. Drugs9(3), 185–194 (2007).
  • Skoner D. Update of growth effects of inhaled and intranasal corticosteroids. Curr. Opin. Allergy Clin. Immunol.2(1), 7–10 (2002).
  • The childhood asthma management program research group. Long-term effects of budesonide or nedocromil in children with asthma. N. Engl. J. Med.343(15), 1054–1063 (2000).
  • Newman SP, Weisz AW, Talaee N, Clarke SW. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax46(10), 712–716 (1991).
  • Thorsson L, Edsbacker S. Lung deposition of budesonide from a pressurized metered-dose inhaler attached to a spacer. Eur. Respir. J.12, 1340–1345 (1998).
  • Aswania O, Ritson S, Iqbal SM, Bhatt J, Rigby AS, Everard ML. Intra-subject variability in lung dose in healthy volunteers using five conventional portable inhalers. J. Aerosol Med.17(3), 231–238 (2004).
  • Borgstrom L, Bengtsson T, Derom E, Pauwels R. Variability in lung deposition of inhaled drug, within and between asthmatic patients, with a pMDI and a dry powder inhaler, turbuhaler. Int. J. Pharm.193(2), 227–230 (2000).
  • Leversha AM, Campanella SG, Aickin RP, Asher MI. Costs and effectiveness of spacer versus nebuliser in young children with moderate and severe acute asthma. J. Pediatr.497–502 (2000).
  • Dewar AL, Stewart A, Cogswell JJ, Connett GJ. A randomised controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute asthma in hospital. Arch. Dis. Childhood421–423 (1999).
  • Gazarian M, Henry R, Wales S et al. Evaluating the effectiveness of evidence-based guidelines for the use of spacer devices in children with acute asthma. Med. J. Aust.174, 394–397 (2001).
  • Robertson C, Norden M, Fitzgerald J, Connor F, Van Asperen P, Cooper P. Treatment of acute asthma: salbutamol via jet nebuliser vs spacer and metered dose inhaler. J. Pediatr. Child Health34(2), 142–146 (1998).
  • Chan PWK, DeBruyne JA. Parental concern towards the use of inhaled therapy in children with chronic asthma. In : Pediatrics International. Blackwell Publishing Limited, Oxford, UK, 547–551 (2000).
  • Apter A, Reisine S, Affleck G, Barrows E, ZuWallack R. Adherence with twice-daily dosing of inhaled steroids. Am. J. Respir. Crit. Care Med.157(6), 1810–1817 (1998).
  • Rubin BK. What does it mean when a patient says, ‘my asthma medication is not working?’. Chest126(3), 972–981 (2004).
  • Bowton D, Goldsmith W, Haponik E. Substitution of metered-dose inhalers for hand-held nebulizers: success and cost savings in a large, acute-care hospital. Chest101(2), 305–308 (1992).
  • Tenholder M, Bryson M, Whitlock W. A model for conversion from small volume nebulizer to metered dose inhaler aerosol therapy. Chest101(2), 305–308 (1992).
  • Summer W, Elston R, Tharpe L, Nelson S, Haponik EF. Aerosol bronchodilator delivery methods. Relative impact on pulmonary function and cost of respiratory care. Arch. Intern. Med.149(3), 618–623 (1989).
  • Restrepo RD, Dickson SK, Rau JL, Gardenhire DS. An investigation of nebulized bronchodilator delivery using a pediatric lung model of spontaneous breathing. Respir. Care51(1), 56–61 (2006).
  • Kishida M, Suzuki I, Kabayama H et al. Mouthpiece versus facemask for delivery of nebulized salbutamol in exacerbated childhood asthma. J. Asthma39, 337 (2002).
  • Lowenthal D, Kattan M. Facemasks versus mouthpieces for aerosol treatment of asthmatic children. Pediatr. Pulmonol.14(3), 192–196 (1992).
  • Mellon M, Leflein J, Walton-Bowen K, Criz-Rivera M, Fitzpatric S, Smith J. Comparable efficacy of administration with facemask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma. Am. J. Respir. Crit. Care Med.162, 593–598 (2000).
  • Kesser B, Geller D, Amirav I, Fink JB. Baby don’t cry: in vitro comparisons of ‘baby’s breath’ aerosol delivery hood versus face mask or blow-by using the saint infant upper airway model and aeroneb go versus t-piece nebulizer. Respir. Care48(11), 1079 (2003).
  • Rubin BK. Bye-bye, blow-by. Respir. Care52(8), 981 (2007).
  • Everard ML, Clark AR, Milner AD. Drug delivery from holding chambers with attached facemask. Arch. Dis. Child67(5), 580–585 (1992).
  • Smaldone GC, Berg E, Nikander K. Variation in pediatric aerosol delivery: importance of facemask. J. Aerosol Med.18(3), 354–363 (2005).
  • Janssens HM, Tiddens HA. Facemasks and aerosol delivery by metered dose inhaler-valved holding chamber in young children: a tight seal makes the difference. J. Aerosol Med.20(Suppl. 1), S59–S63 (2007).
  • Esposito-Festen JE, Ates B, van Vliet FJ, Verbraak AF, de Jongste JC, Tiddens HA. Effect of a facemask leak on aerosol delivery from a pMDI-spacer system. J. Aerosol Med.17(1), 1–6 (2004).
  • Erzinger S, Schueepp KG, Brooks-Wildhaber J, Devadason SG, Wildhaber JH. Facemasks and aerosol delivery in vivo. J. Aerosol Med.20(Suppl. 1), S78–S83 (2007).
  • Morton RW, Mitchell JP. Design of facemasks for delivery of aerosol-based medication via pressurized metered dose inhaler with valved holding chamber: key issues that affect performance. J. Aerosol Med.20(Suppl. 1), S29–S42 (2007).
  • Amirav I, Balanov I, Gorenberg M, Groshar D, Luder AS. Nebuliser hood compared to mask in wheezy infants: aerosol therapy without tears! Arch. Dis. Child.88(8), 719–723 (2003).
  • Amirav I, Oron A, Tal G et al. Aerosol delivery in respiratory syncytial virus bronchiolitis: hood or face mask? J. Pediatr.147(5), 627–631 (2005).
  • Kugelman A, Amirav I, Mor F, Riskin A, Bader D. Hood versus mask nebulization in infants with evolving bronchopulmonary dysplasia in the neonatal intensive care unit. J. Perinatol.26(1), 31–36 (2006).
  • Wilkes W, Fink J, Dhand R. Selecting an accessory device with a metered-dose inhaler: variable influence of accessory devices on fine particle dose, throat deposition, and drug delivery with asynchronous actuation from a metered-dose inhaler. J. Aerosol Med.14, 351 (2001).
  • Brand PL, van der Baan-Slootweg OH, Heynens JW et al. Comparison of handling and acceptability of two spacer devices in young children with asthma. Acta Paediatr.90(2), 133–136 (2001).
  • Nagel M, Doyle C, Avvakoumova VI, Mitchell J, Sharpe R. A breath-actuated nebulizer provides greatly reduced fugitive aerosol emissions compared with a continuously operating nebulizer. Presented at: European Respiratory Society Annual Congress. Stockholm, Sweden, 15–19 September 2007.
  • Fink J. Metered-dose inhalers, dry powder inhalers and transitions. Respir. Care45, 623 (2000).
  • Nikander K, Berg E, Smaldone GC. Jet nebulizers versus pressurized metered dose inhalers with valved holding chambers: effects of the facemask on aerosol delivery. J. Aerosol Med.20(Suppl. 1), S46–S55 (2007).
  • Tal A, Golan H, Aviram M. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. J. Pediatri.1128(4), 479–484 (1996).
  • Bower L, Barnhart S, Betit P, Czervinske M, Masi-Lynch J, Wilson B. AARC clinical practice guideline: selection of an aerosol delivery device for neonatal and pediatric patients. Respir. Care40(12), 1325–1335 (1995).
  • Amirav I, Shakked T, Broday DM, Katoshevski D. Numerical investigation of aerosol deposition at the eyes when using a hood inhaler for infants – a 3D simulation. J. Aerosol Med.21(2), 207–214 (2008).
  • Ari A, Harwood R, Sheard M, Dailey P, Fink JB. In vitro comparison of heliox and oxygen in aerosol delivery using pediatric high flow nasal cannula. Pediatr. Pulmonol.46(8), 795–801 (2011).
  • Bhashyam AR, Wolf MT, Marcinkowski AL et al. Aerosol delivery through nasal cannulas: an in vitro study. J. Aerosol Med.21(2), 181–188 (2008).
  • Lin HL, Restrepo RD, Gardenhire DS, Rau JL. Effect of face mask design on inhaled mass of nebulized albuterol, using a pediatric breathing model. Respir. Care52(8), 1021–1026 (2007).
  • Iles R, Lister P, Edmunds AT. Crying significantly reduces absorption of aerosolised drug in infants. Arch. Dis. Child81(2), 163–165 (1999).
  • Everard ML. Trying to deliver aerosols to upset children is a thankless task. Arch. Dis. Child82(5), 428 (2000).
  • Murakami G, Igarashi T, Adachi Y et al. Measurement of bronchial hyperreactivity in infants and preschool children using a new method. Ann. Allergy64(4), 383–387 (1990).
  • Janssens H, van der Wiel E, Verbraak A, de Jongste J, Merkus P, Tiddens H. Aerosol therapy and the fighting toddler: is administration during sleep an alternative? J. Aerosol Med.16, 395–400 (2003).
  • Esposito-Festen JE, Ijsselstjin H, Hop W, van Vliet F, de Jongste J, Tiddens H. Aerosol therapy by pMDI-spacer in sleeping young children: to do or not to do? Chest130, 487–492 (2006).
  • Yilmaz O, Sogut A, Kose U, Sakinci O, Yuksel H. Influence of ambulatory inhaled treatment with different devices on the duration of acute asthma findings in children. J. Asthma46(2), 191–193 (2009).
  • Wildhaber JH, Dore ND, Wilson JM, Devadason SG, LeSouef PN. Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. J. Pediatr.135(1), 28–33 (1999).
  • Mazhar SH, Ismail NE, Newton DA, Chrystyn H. Relative lung deposition of salbutamol following inhalation from a spacer and a Sidestream jet nebulizer following an acute exacerbation. Br. J. Clin. Pharmacol.65(3), 334–337 (2008).
  • Verberne AA, Frost C, Roorda RJ, van der Laag H, Kerrebijn KF. One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch paediatric asthma study group. Am. J. Respir. Crit. Care Med.156(3 Pt 1), 688–695 (1997).
  • Gray S, Williams D, Pulliam C, Sirgo M, Bishop A, Donohue J. Characteristics predicting incorrect metered-dose inhaler technique in older subjects. Arch. Intern. Med.156(9), 984–988 (1996).
  • Allen S, Prior A. Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age. Postgrad. Med. J.78, 37–39 (2002).
  • McFadden ER Jr. Improper patient techniques with metered dose inhalers: clinical consequences and solutions to misuse. J. Allergy Clin. Immunol.96(2), 278–283 (1995).
  • Goodman D, Israel E, Rosenberg M, Johnston R, Weiss S, Drazen J. The influence of age, diagnosis and gender on proper use of metered dose inhalers. Am. J. Respir. Crit. Care Med.150, 1256–1261 (1994).
  • Atkins PJ. Dry powder inhalers: an overview. Respir. Care50(10), 1304–1312 (2005).
  • Chapman K, Voshaar T, Virchow JC. Inhaler choice in primary practice. Eur. Respir. Rev.14(96), 117–122 (2005).
  • Voshaar T, App E, Berdel D. Recommendations for the choice of inhalatory systems for drug prescription. Pneumologie55, 579–586 (2001).
  • Lavorini F, Magnan A, Dubus JC et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir. Med.102(4), 593–604 (2008).
  • Walia M, Paul L, Satyavani A, Lodha R, Kalaivani M, Kabra SK. Assessment of inhalation technique and determinants of incorrect performance among children with asthma. Pediatr. Pulmonol.41(11), 1082–1087 (2006).
  • Deerojanawong J, Promsaka na Sakolnakorn V, Prapphal N, Hanrutakorn C, Sritippayawan S. Evaluation of metered-dose inhaler administration technique among asthmatic children and their caregivers in Thailand. Asian Pac. J. Allergy Immunol.27, 87–93 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.